Inclusion criteria |
Age ≥ 40 years |
Read, understood and signed the Informed Consent form |
COPD GOLD class III or IV, according to GOLD criteria |
 Post-bronchodilatation FEV1/FVC ≤ 70% and FEV1 < 50% pred.* |
Complaints of refractory dyspnea as established by patient and doctor |
mMRC score ≥ 3 |
Life expectancy of ≥ 2 months |
Optimized standard therapy according to Dutch LAN guideline for diagnosis and treatment of COPD |
Exclusion criteria |
Other severe disease with chronic pain or chronic dyspnea (a non-susbstantial component of left sided heart failure is acceptable) |
Current use of opioids for whatever indication |
Allergy/intolerance for opioids |
Psychiatric disease, not related to severe COPD |
Exacerbation of COPD 8Â weeks prior to inclusion or between screening and randomization |
Problematic (leading to medical help or social problems) substance abuse during the last 5Â years |
Active malignancy, with the exception of planocellular or basal cell carcinoma of the skin |
eGFR < 15 ml/min* |